Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Moberg Pharma AB | 148,864 | net | 10 Jun 2024 | tx 5+148,864 |
| Bioservo Technologies Aktiebolag | 66,666 | net | 09 Jun 2023 | tx 1+66,666 |
| Camurus AB | 21,002 | net | 15 Nov 2021 | tx 4+21,002 |
| Corline Biomedical AB | -5,357 | net | 18 Jun 2018 | tx 2+75,000−80,357 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2024 | OTHER | Moberg Pharma AB | 15,466 | 18.00 SEK | |
| 10 Jun 2024 | OTHER | Moberg Pharma AB | 15,466 | 18.00 SEK | deriv |
| 30 Aug 2023 | PURCHASE | Moberg Pharma AB | 15,466 | 5.75 SEK | |
| 09 Jun 2023 | PURCHASE | Bioservo Technologies Aktiebolag | 66,666 | 1.95 SEK | first after silence |
| 31 May 2022 | GRANT_AWARD | Moberg Pharma AB | 87,000 | 2.30 SEK | |
| 15 Nov 2021 | PURCHASE | Camurus AB | 2,000 | 171.23 SEK | first after silence |
| 25 Mar 2019 | PURCHASE | Camurus AB | 4,982 | 42.00 SEK | |
| 18 Jun 2018 | PURCHASE | Corline Biomedical AB | 75,000 | 11.33 SEK | |
| 18 Jun 2018 | SALE | Corline Biomedical AB | 80,357 | 2.67 SEK | |
| 30 Oct 2017 | PURCHASE | Camurus AB | 9,020 | 120.50 SEK | first after silence |
| 08 Sept 2016 | PURCHASE | Camurus AB | 5,000 | 101.95 SEK |
3 purchases reported after at least 12 months of silence — most recent on 09 Jun 2023.